Mainz Biomed Considers Reverse Stock Split for Nasdaq Compliance

TipRanksNov 15 17:40 ET

The Oncology Bet Is Already Paying Off For Pfizer

BenzingaNov 13 19:23 ET

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets

GlobeNewswireNov 12 09:00 ET

Mainz Biomed Files to Sell 30.77M Ordinary Shares

TipRanksNov 5 08:06 ET

Mainz Biomed Highlights Growth and Innovations for 2025

TipRanksOct 21 08:50 ET

Express News | Mainz Biomed Reported Revenue Of $0.52M For H1 2024, Up By 4% YoY, EPS Loss Of $(0.49)

BenzingaOct 21 08:06 ET